Administration of pancreatic enzymes (pancrelipase) to adult patients with cystic fibrosis when receiving enteral nutrition through a feeding tube is challenging. A number of techniques for preparing and administering the drug may result in complications that include feeding tube occlusion and inadequate enzyme delivery to the patient. A series of inpatient encounters is described.
TrapnellBCMaguinessKGraffGR. Efficacy and safety of Creon® 24,000 in subjects with exocrine pancreatic insufficiency due to cystic fibrosis. J Cyst Fibros. 2009;8:370-377.
2.
WooldridgeJLHeubiJEAmaro-GalvezR. EUR-1008 pancreatic enzyme replacement is safe and effective in patients with cystic fibrosis and pancreatic insufficiency. J Cyst Fibros. 2009;8:405-417.
3.
TrapnellBCStrausbaughSDWooMS. Efficacy and safety of PANCREAZE® for treatment of exocrine pancreatic insufficiency due to cystic fibrosis. J Cyst Fibros. 2011;10:350-356.
BoullataJI. Drug administration through an enteral feeding tube: the rationale behind the guidelines. Am J Nurs. 2009;109(10):34-42.
13.
BankheadRBoullataJBrantleyS, and A.S.P.E.N.Board of Directors. Enteral nutrition practice recommendations. JPEN J Parenter Enteral Nutr. 2009;33:122-167.
HoekstraJHvan den AkerJHLGhoosYFHarteminkRKneepkensCMF. Fluid intake and industrial processing in apple juice induced chronic non-specific diarrhea. Arch Dis Child. 1995;73:126-130.
19.
ShlieoutGKoernerAMaffertMForssmannKCarasS.Administration of CREON pancrelipase pellets via gastrostomy tube is feasible with no loss of gastric resistance or lipase activity. Clin Drug Invest. 2011;31:e1-e7.
20.
WhiteRBradnamV, eds. Handbook of Drug Administration via Enteral Feeding Tubes. 2nd ed.London, UK: Pharmaceutical Press; 2011.
21.
KlangMMcLymontVNgN. Osmolality, pH and compatibility of selected oral liquid medications with an enteral nutrition product [published online January 17, 2013]. JPEN J Parenter Enteral Nutr. doi:10.1177/0148607112471560.
